Journal of Clinical Endocrinology & Metabolism, Vol 68, 9-16, Copyright © 1989 by Endocrine Society

ARTICLES

Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia

MJ Sotsky, S Shilo and H Shamoon
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.

We examined the role of the plasma glucose concentration per se in the secretion of counterregulatory hormones during exercise. Ten men (average age, 24 yr; maximal aerobic capacity, 31.8 mL/kg.min) were studied during two 50-min bicycle exercise periods at either normal glucose [87 +/- 1 (+/- SE) mg/dL (4.8 +/- 0.1 mmol/L)] or low glucose [59 +/- 1 mg/dL (3.3 +/- 0.1 mmol/L)]. The plasma glucose targets were achieved by exogenous insulin and variable glucose infusions. These results were compared to studies in which saline was infused. Exercise at normal glucose was associated with significant increments in plasma epinephrine (maximum 3- to 5-fold above baseline) and norepinephrine (2- fold), comparable to those that occurred during saline administration. Plasma GH increased only at the most intense exercise level, while plasma cortisol and glucagon did not increase significantly. In low glucose-exercise studies, the increase in plasma epinephrine during exercise was significantly greater than that at normal glucose (P less than 0.01), although proportional to basal preexercise levels (r = 0.73; P less than 0.001). Plasma glucagon increased almost 100%, and plasma cortisol and GH increased by 150% and 400%, respectively. Compared to the effect of the same degree of hypoglycemia in the absence of exercise, only plasma epinephrine (P = 0.002) and norepinephrine (P less than 0.001) displayed effects independent of hypoglycemia during exercise. When low glucose was reversed to normal at the midpoint of exercise, plasma epinephrine and glucagon returned to the levels obtained for the same duration of exercise at normal glucose, while norepinephrine, GH, and cortisol were only partially responsive to the rise in plasma glucose. These data suggest that 1) moderate exercise is a stimulus for a sympathoadrenal and GH response, but not a peripheral glucagon response; 2) during exercise and hypoglycemia, plasma epinephrine and norepinephrine are enhanced, while the glucagon response is entirely glucose dependent; and 3) the epinephrine response to hypoglycemia can be dissociated from that to exercise, suggesting differing control mechanisms. We conclude that the activation of counterregulatory hormones during exercise is regulated by glucose-independent mechanisms, although these responses may be augmented by concurrent hypoglycemia.

This article has been cited by other articles:

				I. Gabriely and H. Shamoon Fructose Normalizes Specific Counterregulatory Responses to Hypoglycemia in Patients With Type 1 Diabetes Diabetes, March 1, 2005; 54(3): 609 - 616. [Abstract] [Full Text] [PDF]

				P. Galassetti, D. Tate, R. A. Neill, S. Morrey, D. H. Wasserman, and S. N. Davis Effect of Antecedent Hypoglycemia on Counterregulatory Responses to Subsequent Euglycemic Exercise in Type 1 Diabetes Diabetes, July 1, 2003; 52(7): 1761 - 1769. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, K. Reddy, L. Rossetti, and H. Shamoon Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects Diabetes, July 1, 2002; 51(7): 2179 - 2189. [Abstract] [Full Text] [PDF]

				I. Gabriely, M. Hawkins, C. Vilcu, L. Rossetti, and H. Shamoon Fructose Amplifies Counterregulatory Responses to Hypoglycemia in Humans Diabetes, April 1, 2002; 51(4): 893 - 900. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon, and L. Rossetti Fructose Improves the Ability of Hyperglycemia Per Se to Regulate Glucose Production in Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 606 - 614. [Abstract] [Full Text] [PDF]

				I. Gabriely, R. Wozniak, M. Hawkins, and H. Shamoon Troglitazone Amplifies Counterregulatory Responses to Hypoglycemia in Nondiabetic Subjects J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 521 - 528. [Abstract] [Full Text]

				M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429. [Abstract] [Full Text] [PDF]

				S. N. Davis, P. Galassetti, D. H. Wasserman, and D. Tate Effects of Gender on Neuroendocrine and Metabolic Counterregulatory Responses to Exercise in Normal Man J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 224 - 230. [Abstract] [Full Text]

				B. Eden Engstrom, F. A. Karlsson, and L. Wide Gender Differences in Diurnal Growth Hormone and Epinephrine Values in Young Adults during Ambulation Clin. Chem., August 1, 1999; 45(8): 1235 - 1239. [Abstract] [Full Text] [PDF]

				B. E. Engstrom, F. A. Karlsson, and L. Wide Marked gender differences in ambulatory morning growth hormone values in young adults Clin. Chem., June 1, 1998; 44(6): 1289 - 1295. [Abstract] [Full Text] [PDF]

				A. J. Scheen, O. M. Buxton, M. Jison, O. Van Reeth, R. Leproult, M. L'Hermite-Baleriaux, and E. Van Cauter Effects of exercise on neuroendocrine secretions and glucose regulation at different times of day Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1040 - E1049. [Abstract] [Full Text] [PDF]